Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Cripe

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
The Journal of Clinical Investigation|November 3, 2015
Histone deacetylase 6 inhibition enhances oncolytic viral replication in gliomaHiroshi Nakashima, Johanna K Kaufmann, Pin-Yi Wang, et al.
The British Journal of Radiology|January 24, 2022
Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumorsSujith Baliga, Jennifer Matsui, Brett Klamer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2019
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical TrialKeri A Streby, Mark A Currier, Melinda Triplet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2014
Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effectsJi Young Yoo, Brian S Hurwitz, Chelsea Bolyard, et al.
Oncotarget|February 2, 2017
Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulationMark A Currier, Les Sprague, Tilat A Rizvi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2014
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patientsTimothy P Cripe, Minhtran C Ngo, James I Geller, et al.
Iscience|July 19, 2021
Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcomaMary Frances Wedekind, Katherine E Miller, Chun-Yu Chen, et al.
Molecular Therapy. Methods & Clinical Development|August 13, 2025
Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engagerMark A Currier, Allen Reha, Brian Hutzen, et al.
Molecular Therapy Oncolytics|August 16, 2023
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolutionJack Hedberg, Adam Studebaker, Luke Smith, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
The Journal of Clinical Investigation|November 3, 2015
Histone deacetylase 6 inhibition enhances oncolytic viral replication in gliomaHiroshi Nakashima, Johanna K Kaufmann, Pin-Yi Wang, et al.
The British Journal of Radiology|January 24, 2022
Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumorsSujith Baliga, Jennifer Matsui, Brett Klamer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 2, 2019
First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical TrialKeri A Streby, Mark A Currier, Melinda Triplet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2014
Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effectsJi Young Yoo, Brian S Hurwitz, Chelsea Bolyard, et al.
Oncotarget|February 2, 2017
Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulationMark A Currier, Les Sprague, Tilat A Rizvi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2014
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patientsTimothy P Cripe, Minhtran C Ngo, James I Geller, et al.
Iscience|July 19, 2021
Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcomaMary Frances Wedekind, Katherine E Miller, Chun-Yu Chen, et al.
Molecular Therapy. Methods & Clinical Development|August 13, 2025
Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engagerMark A Currier, Allen Reha, Brian Hutzen, et al.
Molecular Therapy Oncolytics|August 16, 2023
Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolutionJack Hedberg, Adam Studebaker, Luke Smith, et al.
Pageof 13